Senate Hearing on Marijuana and Public Health
January 1, 2021
Track this bill to get notified when it advances a stage. One tap to stop, anytime.
The Frame
The hearing establishes the current federal legislative baseline for evaluating potential changes to marijuana policy by identifying what medical evidence is considered conclusive versus insufficient for future regulation.
Potentially affected actors named in the source documents. Mention is not a position.
Adolescents
The Surgeon General has identified this group as being at higher risk for negative health outcomes from marijuana use.
Pregnant and nursing women
This group is identified as a vulnerable population with specific health risks associated with marijuana use.
Medical researchers
Policymakers are seeking conclusive, peer-reviewed evidence from this group to inform future federal policy.
Last recorded activity January 1, 2021.
Next step not available in the current record.
Summary
Key Facts
- Marijuana usage among Americans 12 and older increased from under 7% in 2010 to over 10% in 2018.
- An estimated 43.5 million Americans used marijuana in 2018.
- 10 states and the District of Columbia allow recreational marijuana use.
- Over 90% of states allow for some form of medical marijuana use.
- The National Academy of Sciences found conclusive evidence that cannabinoids are effective for treating chronic pain and chemotherapy-induced nausea.
- The National Academy of Sciences found substantial evidence linking marijuana use to increased risk of motor vehicle crashes, schizophrenia, and pregnancy complications like low birth weight.
- The FDA approved the first marijuana-derived drug in 2018 for treating rare forms of epilepsy.
- The Surgeon General issued an advisory regarding the risks of marijuana use for pregnant women and adolescents.
Frequently Asked Questions
Is marijuana legal under federal law?
What health conditions does the government recognize as treatable by cannabinoids?
Why It Matters
The hearing establishes the current federal legislative baseline for evaluating potential changes to marijuana policy by identifying what medical evidence is considered conclusive versus insufficient for future regulation.
News Coverage
Sponsors
Discoveries
Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.
Evidence-Based Policy Gap
The committee explicitly stated that federal policy changes are being delayed due to a lack of conclusive, peer-reviewed scientific evidence on marijuana's health effects.
Connected Entities
Sources
www.govinfo.gov
Analysis Score
0–100- Significance75How much this matters to a regular citizen
- Controversy40Intensity of disagreement among stakeholders
- Entertainment10Compellingness for a non-policy-wonk reader
- Buzz20Current news / social attention level
Publisher tools